Company Search:
Advanced Search
Sponsored Links
Pharmaxis Ltd Company Snapshot
Pharmaxis Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other companies in this sector in Australia: Clinuvel Pharmaceuticals Limited (2018 sales of 25.75 million Australian Dollars [US$18.33 million] of which 100% was Biotechnology), Xrf Scientific Ltd (24.25 million Australian Dollars [US$17.26 million] of which 42% was Precious Metals), and Mesoblast Ltd (22.42 million Australian Dollars [US$15.96 million] of which 100% was Mesenchymal Precursor Cell).

Sales Analysis. Sales increased substantially in 2018: During the year ended June of 2018, sales at Pharmaxis Ltd were A$50.33 million (US$35.82 million). This is an increase of 185.4% versus 2017, when the company's sales were A$17.64 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pharmaxis Ltd
  Stock Performance Chart for Pharmaxis Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): .31
(Figures in Australian Dollars)
1 Week 1.7%   13 Weeks -3.2%  
4 Weeks -3.2%   52 Weeks 17.3%  
Pharmaxis Ltd Key Data:
  Ticker: PXS Country: Australia
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 50,332,000
(Year Ending Jan 2019).
Employees: 107
  Currency: Australian Dollars Market Cap: 97,532,395
  Fiscal Yr Ends: June Shares Outstanding: 319,778,344
  Share Type: Ordinary Closely Held Shares: 48,725,588
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.